I agree that this site is using cookies. You can find further informations here.
X
Bachier, Carlos
72  results:
Search for persons X
?
1

A robust quality infrastructure is key to safe and effectiv..:

Curran, Kevin J. ; Nikiforow, Sarah ; Bachier, Carlos...
Blood Advances.  8 (2024)  4 - p. 1053-1061 , 2024
Link: https://doi.org/10.1182/..
 
?
2

PB2346: ZUMA-24: A PHASE 2, OPEN-LABEL, MULTICENTER STUDY O..:

Leslie, Lori ; Tees, Michael ; Flinn, Ian W....
HemaSphere.  7 (2023)  S3 - p. e50042ff , 2023
Link: https://doi.org/10.1097/..
 
?
3

Access Barriers for Anti-CD19+ Chimeric Antigen Receptor T ..:

Battiwalla, Minoo ; Tees, Michael ; Flinn, Ian W....
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S55 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Outcomes for Anti-CD19+ Chimeric Antigen Receptor T (CAR-T)..:

Battiwalla, Minoo ; Tees, Michael ; Flinn, Ian W....
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S211 , 2023
Link: https://doi.org/10.1016/..
 
?
5

POSTER: CT-045 Primary Results From OUTREACH: A Phase II St..:

Linhares, Yuliya ; Freytes, Cesar ; Cherry, Mohamad...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S233 , 2023
Link: https://doi.org/10.1016/..
 
?
6

CT-045 Primary Results From OUTREACH: A Phase II Study of L..:

Linhares, Yuliya ; Freytes, Cesar ; Cherry, Mohamad...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S514-S515 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Dual targeting of CD19 and CD22 with Bicistronic CAR-T cell..:

Roddie, Claire ; Lekakis, Lazaros J. ; Marzolini, Maria A. V....
Blood.  , 2023
Link: https://doi.org/10.1182/..
 
?
8

Outcomes of a Conditioning Regimen Including Carmustine and..:

Zeilmann, Dominik ; Horowitz, Justin ; Bachier, Carlos.
Transplantation and Cellular Therapy.  28 (2022)  3 - p. S237-S238 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Adoptive cellular therapy in acute myeloid leukemia: Curren..:

Arora, Sankalp ; Asawa, Palash ; Ramakrishnan, Aravind..
Hematology/Oncology and Stem Cell Therapy.  15 (2022)  3 - p. , 2022
Link: https://doi.org/10.56875..
 
?
10

Bu2Flu Reduced Intensity Conditioning Is Associated with Po..:

Pantin, Jeremy ; Egan, Tiffany ; Frangoul, Haydar...
Transplantation and Cellular Therapy.  28 (2022)  3 - p. S246-S247 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Plan and Execute a Successful Virtual FACT Inspection with ..:

Lewis, Karen ; Battiwalla, Minoo ; Blunk, Betsy...
Transplantation and Cellular Therapy.  28 (2022)  3 - p. S446-S447 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Phase I clinical trial evaluating the safety and efficacy o..:

Blumenschein, George R ; Devarakonda, Siddhartha ; Johnson, Melissa...
Journal for ImmunoTherapy of Cancer.  10 (2022)  1 - p. e003581 , 2022
Link: https://doi.org/10.1136/..
 
?
13

The impact of early versus late tocilizumab administration ..:

Peaytt, Rachel ; Parsons, Laura Beth ; Siler, Darby...
Journal of Oncology Pharmacy Practice.  29 (2021)  1 - p. 45-51 , 2021
Link: https://doi.org/10.1177/..
 
?
14

Survival outcomes of allogeneic hematopoietic cell transpla..:

Naik, Seema ; Riches, Marcie ; Hari, Parameswaran...
Transplant Infectious Disease.  21 (2019)  5 - p. , 2019
Link: https://doi.org/10.1111/..
 
?
15

Pharmacoeconomic Analysis and Clinical Outcomes of Staggere..:

Elayan, Mohammed M. ; Kim, Ted Y. ; Siler, Darby...
Biology of Blood and Marrow Transplantation.  23 (2017)  3 - p. S269-S270 , 2017
Link: https://doi.org/10.1016/..
 
1-15